{"id":113001,"date":"2014-10-17T13:35:00","date_gmt":"2014-10-17T13:35:00","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=113001"},"modified":"2014-10-17T13:35:00","modified_gmt":"2014-10-17T13:35:00","slug":"vanzarile-globale-ale-roche-au-crescut-cu-5-in-primele-noua-luni-din-2014","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=113001","title":{"rendered":"V\u00e2nz\u0103rile globale ale Roche au crescut cu 5% \u00een primele nou\u0103 luni din 2014"},"content":{"rendered":"<p>\nDivizia de Farmaceutice a \u00eenregistrat, \u00een primele nou\u0103 luni, o cre\u015ftere \u00een v\u00e2nz\u0103ri de 4%, datorat\u0103 cererii sus\u0163inute pentru medicamentele oncologice \u015fi \u00een special pentru moleculele destinate tratamentului cancerului de s\u00e2n HER2 pozitiv. Divizia de Diagnostic a \u00eenregistrat, \u00een aceea\u015fi perioad\u0103, o cre\u015ftere de 6% a v\u00e2nz\u0103rilor, \u00een principal datorit\u0103 performan\u0163ei Professional Diagnostics.<\/p>\n<p>\n\u201cAvem ve\u015fti \u00een ceea ce prive\u015fte linia noastr\u0103 de cercetare \u015fi de dezvoltare, ce include rezultate favorabile pentru o nou\u0103 molecul\u0103 \u00een tratamentul cancerului de s\u00e2n HER2 pozitiv \u015fi pentru o nou\u0103 combina\u0163ie terapeutic\u0103 \u00een melanom. Achizi\u0163ia InterMune ne-a consolidat portofoliul cu o nou\u0103 molecul\u0103 pentru fibroza pulmonar\u0103 idiopatic\u0103, aprobat\u0103 recent de FDA. \u00cen ceea ce prive\u015fte Divizia de Diagnostic, cre\u015fterea continu\u0103 este dat\u0103 de achizi\u0163ia unei noi genera\u0163ii de sisteme de testare, care ne-au \u00eent\u0103rit pozi\u0163ia \u00een diagnosticul molecular\u201d, a declarat Severin Schwan, CEO al grupului Roche<\/p>\n<p>\nV\u00e2nz\u0103rile Diviziei de Farmaceutice a Roche au crescut cu 4% \u00een primele nou\u0103 luni ale anului 2014, la o rat\u0103 de schimb constant\u0103, ajung\u00e2nd la 26.96 miliarde de franci elve\u0163ieni. Aceast\u0103 cre\u015ftere s-a datorat \u00een special francizei de medicamente pentru tratamentul cancerului de s\u00e2n HER2 pozitiv &#8211; care a \u00eenregistrat o cre\u015ftere de 21% . V\u00e2nz\u0103rile au \u00eenregistrat o cre\u015ftere de 5% \u00een Statele Unite, de 7% \u00een Japonia \u015fi de 3% \u00een Europa.<\/p>\n<p>\nPrin preluarea companiei InterMune, Roche a ad\u0103ugat portofoliului s\u0103u un nou medicament pentru fibroz\u0103 pulmonar\u0103 idiopatic\u0103, care a primit aprobare \u00een Statele Unite \u00een luna octombrie a acestui an. Tranzac\u0163ia, \u00een valoare total\u0103 de 5.75 miliarde de dolari americani, s-a finalizat \u00een luna septembrie.<\/p>\n<p>\nPentru anul 2014, Roche prognozeaz\u0103 o cre\u015ftere de o singur\u0103 cifra a v\u00e2nz\u0103rilor, la o rat\u0103 de schimb constant\u0103 \u015fi o cre\u015ftere a dividendelor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Grupul farmaceutic elve\u0163ian Roche anun\u0163\u0103 o cre\u015ftere a v\u00e2nz\u0103rilor globale \u00een primele 9 luni ale anului 2014, cu 5%, la o rat\u0103 de schimb constant\u0103, ajung\u00e2nd la 34.75 miliarde de franci elve\u0163ieni.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[30466,8088,8623,12923,7212],"class_list":["post-113001","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-elvetieni","tag-farma","tag-roche","tag-tratament","tag-vanzari"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/113001","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=113001"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/113001\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=113001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=113001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=113001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}